Effect of the Genotype on Postoperative DVT
NCT04940377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 502505
Last updated 2021-06-30
Summary
Postoperative Venous Thromboembolism Events (VTE) constitute a major source of morbidity and mortality after surgery. The aim of this study was to investigate whether commonly occurring Single Nucleotide Polymorphisms (SNPs) are associated with VTE in the surgical setting.
Conditions
- Venous Thromboembolism
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2021-03-01
- Completion
- 2021-06-01
Countries
- Denmark
Study Locations
More Related Trials
-
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
NCT05515549 ·Status: UNKNOWN
-
Venous Thrombosis in Turner Syndrome
NCT00594763 ·Status: UNKNOWN
-
Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery
NCT01976988 ·Status: COMPLETED ·Phase: PHASE3
-
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
NCT00927862 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
NCT00395265 ·Status: COMPLETED
-
Association Between Genetic Variant Scores and Warfarin Effect
NCT03894878 ·Status: COMPLETED
-
Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
NCT01006733 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
NCT00511173 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)
NCT00634907 ·Status: COMPLETED ·Phase: NA
-
Optimal Duration of Anticoagulation in Deep Venous Thrombosis
NCT01285661 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding Risk Factors Involved in Developing a Second Blood Clot.
NCT00261014 ·Status: UNKNOWN
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor
NCT07342127 ·Status: COMPLETED
-
Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
NCT00788736 ·Status: COMPLETED
-
Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism
NCT01559207 ·Status: COMPLETED
-
Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome
NCT04597138 ·Status: COMPLETED
-
Cohort for Monitoring Patients With Venous Thromboembolic Disease
NCT07016542 ·Status: RECRUITING
-
Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty
NCT03275610 ·Status: ENROLLING_BY_INVITATION
-
VTE Risk Prevention System Based on Big Data Analysis and Multimodule System
NCT05969951 ·Status: RECRUITING
-
Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
NCT02258958 ·Status: COMPLETED
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
NCT01446510 ·Status: WITHDRAWN
-
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
NCT01610141 ·Status: UNKNOWN ·Phase: PHASE4
-
Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis
NCT03977870 ·Status: COMPLETED
-
Incidence and Outcomes of Venous Thromboembolism
NCT00005351 ·Status: COMPLETED